D. A. Sweet

A Study Comparing Dosing Regimens and Efficacy of Subcutaneous to Intravenous Azacitidine (AZA) for the Treatment of Myelodysplastic Syndromes (MDS).

D. Donley, J. Maciejewski, M. Sekeres, 2009 .

Treatment of Patients with Low-Risk Myelodysplastic Syndromes Receiving Azacitidine Who Are Enrolled in AVIDA, a Longitudinal Patient Registry.

J. Malone, M. Narang, D. Grinblatt, 2008 .